SCM
AVIR icon

Sterling Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History

Sterling Capital Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$7.85K Buy
2,180
+849
+64% +$3.06K ﹤0.01% 2277
2025
Q1 		$3.98K Sell
1,331
-1,141
-46% -$3.41K ﹤0.01% 2278
2024
Q4 		$8.28K Buy
2,472
+2,227
+909% +$7.46K ﹤0.01% 2248
2024
Q3 		$821 Buy
+245
New +$821 ﹤0.01% 2641